SPM927/Lacosamide

DRUG3 trials

Sponsors

UCB Pharma

Conditions

Painful Diabetic NeuropathyPostherpetic Neuralgia

Phase 2

A Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy

CompletedNCT00861445

UCB PharmaPainful Diabetic Neuropathy

Start: 2001-06-30End: 2003-02-28Updated: 2014-10-20

A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).

CompletedNCT00861068

UCB PharmaPostherpetic Neuralgia

Start: 2002-02-28End: 2003-01-31Updated: 2024-04-19

An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy

CompletedNCT00861042

UCB PharmaPainful Diabetic Neuropathy

Start: 2002-04-30End: 2005-03-31Updated: 2024-01-29

Related Papers

Safety and tolerability of lacosamide monotherapy in the elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain.

2017-09-115 citations

Safety and tolerability of lacosamide monotherapy in elderly: A subgroup analysis from lacosamide trials in diabetic neuropathic pain (P1.239)

Neurology2015-04-06